Literature DB >> 10655245

Microstructural evolution of lipid aggregates in nucleating model and human biles visualized by cryogenic transmission electron microscopy.

F M Konikoff1, D Danino, D Weihs, M Rubin, Y Talmon.   

Abstract

Obtaining reliable information on the physical state and ultrastructure of bile is difficult because of its mixed aqueous-lipid composition and thermodynamic metastability. We have used time-lapse cryogenic transmission electron microscopy (cryo-TEM) combined with video-enhanced light microscopy (VELM) to study microstructural evolution in nucleating bile. A well-characterized model bile and gallbladder biles from cholesterol and pigment gallstone patients were studied sequentially during cholesterol nucleation and precipitation. In model bile, cholesterol crystallization was preceded by the appearance of the following distinct microstructures: spheroidal micelles (3-5 nm), discoidal membrane patches (50-150 nm) often in multiple layers (2-10), discs (50-100 nm), and unilamellar (50-200 nm) and larger multilamellar vesicles (MLVs). The membrane patches and discs appeared to be short-lived intermediates in a micelle-to-vesicle transition. Vesicular structures formed by growth and closure of patches as well as by budding off from vesicles with fewer bilayers. MLVs became more abundant, uniform, and concentric as a function of time. In native bile, all the above microstructures, except discoidal membrane patches, were observed. However, native MLVs were more uniform and concentric from the beginning. When cholesterol crystals appeared by light microscopy, MLVs were always detected by cryo-TEM. Edges of early cholesterol crystals were lined up with micelles and MLVs in a way suggesting an active role in feeding crystal growth from these microstructures. These findings, for the first time documented by cryo-TEM in human bile, provide a microstructural framework that can serve as a basis for investigation of specific factors that influence biliary cholesterol nucleation and crystal formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655245     DOI: 10.1002/hep.510310202

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  Cholesterol monohydrate nucleation in ultrathin films on water.

Authors:  H Rapaport; I Kuzmenko; S Lafont; K Kjaer; P B Howes; J Als-Nielsen; M Lahav; L Leiserowitz
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

2.  Trapping crystal nucleation of cholesterol monohydrate: relevance to pathological crystallization.

Authors:  Inna Solomonov; Markus J Weygand; Kristian Kjaer; Hanna Rapaport; Leslie Leiserowitz
Journal:  Biophys J       Date:  2004-12-13       Impact factor: 4.033

3.  Recent understanding of cholesterol gallstone pathogenesis: implication to non-surgical therapeutic strategy.

Authors:  Susumu Tazuma
Journal:  Clin J Gastroenterol       Date:  2008-10-31

Review 4.  Genetic Analysis of ABCB4 Mutations and Variants Related to the Pathogenesis and Pathophysiology of Low Phospholipid-Associated Cholelithiasis.

Authors:  Helen H Wang; Piero Portincasa; Min Liu; David Q-H Wang
Journal:  Genes (Basel)       Date:  2022-06-11       Impact factor: 4.141

5.  A kinetic study of the growth of fatty acid vesicles.

Authors:  Irene A Chen; Jack W Szostak
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

6.  Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption.

Authors:  Suha Attili-Qadri; Nour Karra; Alina Nemirovski; Ouri Schwob; Yeshayahu Talmon; Taher Nassar; Simon Benita
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

7.  Live-cell imaging in Caenorhabditis elegans reveals the distinct roles of dynamin self-assembly and guanosine triphosphate hydrolysis in the removal of apoptotic cells.

Authors:  Bin He; Xiaomeng Yu; Moran Margolis; Xianghua Liu; Xiaohong Leng; Yael Etzion; Fei Zheng; Nan Lu; Florante A Quiocho; Dganit Danino; Zheng Zhou
Journal:  Mol Biol Cell       Date:  2009-12-16       Impact factor: 4.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.